期刊文献+

深圳地区结核临床分离菌基因突变与耐药的关系 被引量:8

Association between gene mutations and the development of drug resistance of Mycobacterium tuberculosis from the clinical isolates from Shenzhen
原文传递
导出
摘要 目的研究深圳地区结核分枝杆菌临床分离株的基因突变与利福平(RFP)、异烟肼(INH)、链霉素(SM)和乙胺丁醇(EMB)耐药之间的关系。方法采用反向斑点杂交技术(RDBHA)对182株结核分枝杆菌临床分离株的rpoB、katG、inhA、rpsL和embB基因突变位点进行检测,并采用L-J比例法检测这些分离株对RFP、INH、SM、EMB的耐药性。结果 182株临床分离株中,总的基因突变率为34.62%(63/182),其中rpoB基因突变率最高,达24.17%(44/182)。多重耐药结核菌(MDR-TB)占17.03%(31/182)。以L-J比例法作为金标准,采用RDBHA技术检测分别与RFP、INH、SM、EMB耐药相关的rpoB、katG/inhA、rpsL、embB基因突变,其灵敏度分别为88.89%、67.50%、81.82%和64.29%,特异度分别为97.08%、94.37%、97.99%和92.86%。结论深圳地区结核分离株ropB基因突变最普遍,S531L位点是其突变率最高的位点。深圳地区结核分枝杆菌对4个一线抗痨药物耐药现象均较严重,反向斑点杂交技术(RDBHA)可快速检测结核分枝杆菌耐药基因突变,能给临床提供快速用药指导。 Objective To investigate possible association between the gene mutations and the development of rifampin (RFP),isoniazid (INH),streptomycin (SM),and ethambutol (EMB) resistance of Mycobacterium tuberculosis isolated from Shenzhen.Methods 182 MTB clinical isolates from Shenzhen were extensively analyzed for their rpoB,katG,inhA,rpsL and embB mutations using the reverse dot blot hybridization assay (RDBHA).L-J slant proportion method was used to evaluate the susceptibility of the isolates to INH,RFP,SM,and EMB.Results The overall frequency of gene mutation was 34.62% (63/182),and rpoB had the highest mutation frequency (24.17%,44/182).The frequency of MDR-TB was 17.03% (31/182) among the 182 isolates.The sensitivity to rpoB,katG/inhA,rpsL,and embB was 88.89%,67.50%,81.82% and 64.29%,respectively;and the specificity was 97.08%,94.37%,97.99% and 92.86%,respectively.Conclusions Mutation of ropB,especially the S531L mutation,is commonly found in the isolates.Most of the isolate were resistant to the four first-line anti-tuberculosis drugs.RDBHA can be used for fast detection of drug resistance.
出处 《热带医学杂志》 CAS 2013年第8期939-943,共5页 Journal of Tropical Medicine
基金 国家科技重大专项十二五计划(2013ZX10003001) 深圳市结核病临床重点专科专项基金
关键词 结核分枝杆菌 耐药 基因突变 Mycobacterium tuberculosis drug resistance gene mutation
  • 相关文献

参考文献27

  • 1Cox H , Allamuratova S , Davletmuratova Z , et al.Tuberculosis recurrence and mortality after successful treatment: Impact of drag resistanee[J ].PLOS Med, 2006,3 (10) : 1836-1843. 被引量:1
  • 2Zignol M,Wright A,Nunn P,et al.Global incidence of muhidrug-resistant tuberculosis [ J ].J Infect Dis, 2006,194 (4) : 479-485. 被引量:1
  • 3Wright A, Zignol M, Van Deun A, et al.Epidemiology of antituberculosis drug resistance 2002-2007: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance [ J ].Lancet, 2009,373 ( 9678 ) : 1861-1873. 被引量:1
  • 4Cheng MH.Ministerial meeting agrees plan for tuberculosis control [ Z ]. 2009. 被引量:1
  • 5Fan XY,Xu Fl-I,Guo SQ.Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in Shanghai by using the amplification refractory mutation system[J].J Clin Microbiol,2003,41(3) :993-997. 被引量:1
  • 6Mokrousov I, Suffys PN, Yap SF, et al.Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates [J].J Microbiol Meth, 2004,57 (3) : 323-335. 被引量:1
  • 7Bartfai Z, Kodmon C, Puskas E, et al.Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay [J].J Clin Mierobiol, 2001,39(10) : 3736-3739. 被引量:1
  • 8Newton CR,Graham A,Heptinstall LE,et al.Analysis of any point mutation in DNA.The amplification refractory mutation system (ARMS) [J]. Nucleic Acids Res, 1989,17 (7) :2503- 2516. 被引量:1
  • 9Yam WC,Leung CC,Chan KH,et al.Direct detection of rifampin-resistant Mycobacterium tuberculosis in respiratory specimens by PCR-DNA Sequencing[J].J Clin Microbiol,200d, 42(10) :4438-4443. 被引量:1
  • 10Huang H,Jin Q,Ma Y,et al.Characterization of rpoB mutations in rifampiein-resistant Mycobacterium tuberculosis isolated in China [ J 1.Tuberculosis (Edinb), 2002,82 ( 2-3 ) : 79- 83. 被引量:1

二级参考文献17

  • 1李芳芳,方红辉,何林,吴伟元,廖生赟,张舒林.结核分枝杆菌耐药基因rpoB.katG.inhA突变快速检测方法研究[J].热带医学杂志,2005,5(6):743-746. 被引量:7
  • 2结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 3MORRISS S,BAI G H,SUFFLYS P,et al.Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis[J].J Infect Dis,1995,171 (4):954-960. 被引量:1
  • 4Edwards K J, Metherell LA. Detection of rpoB Mutations in Mycobaterium tuberculosis by Biprobe Analysis [J]. J Amer Soci for Micro, 2001,39 (9): 3350-3352. 被引量:1
  • 5Daiva B, Aurelija B. Molecular characteri-zation of IsoniazidResistant Mycobacterium tuberculosis clinical isolates in lithuania[J]. J Am Soci for Micro, 2003, 47(6):2009-2011. 被引量:1
  • 6Laura Rindi, Lea Bianchi. A real-time PCR assay for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates[ J ]. J of Microbiol Meth, 2003,55:797-800. 被引量:1
  • 7Márcia SN, Silva SG. Mutations in katG, inhA, and ahpC Genes of brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis [J]. J Clin Microbiol, 2003,41 (9):4471-4474. 被引量:1
  • 8Rindi L, Bianchi L, Tortoli E, et al. Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy [J ].Int J Tuberc Lung Dis, 2005,9: 94-97. 被引量:1
  • 9Garcia de Viedma D, del Sol Diaz infants M, Lasala F,et al.New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis [J]. J Clin Microbiol,2002,40: 988-995. 被引量:1
  • 10Morris S, Bai GH, Suffys P, et al. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis[J]. J Infect Dis, 1995, 171:954-960. 被引量:1

共引文献12

同被引文献84

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部